Clinical Trials Directory

Trials / Completed

CompletedNCT01975025

Hemodialysis Frequency and the Calcification Propensity of Serum

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this clinical research project is to test the hypothesis that daily dialysis has favorable effects on the calcification propensity of human serum, when determined by the investigators' newly developed in vitro serum test. The investigators' hypothesis is that shorter interdialytic intervals will result in an improved calcification propensity of serum. The determination of serum calcification has the potential to become a novel measure of dialysis quality in the future.

Detailed description

Background The serum calcification test has been established and validated by A. Pasch and coworkers, the expertise to perform the necessary statistical analyses is present in the investigator's department, all patient-related procedures necessary for this project are routinely performed in the investigator's department. Objective Does short daily hemodialysis strengthen the calcification-inhibitory forces inherent in hemodialysis patient sera, when compared to conventional three-times weekly hemodialysis? Methods Serum calcification test

Conditions

Interventions

TypeNameDescription
PROCEDUREShort daily dialysis for 2 weeks

Timeline

Start date
2014-06-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2013-11-04
Last updated
2016-04-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01975025. Inclusion in this directory is not an endorsement.